共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R032632-5mg | 5mg | 现货 |
反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并... PF-04620110 |
99% |
|
|
阿拉丁 | P127261-5mg | 5mg | 现货 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-10mg | 10mg | 现货 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-50mg | 50mg | 现货 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-100mg | 100mg | 现货 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P127261-25mg | 25mg | 现货 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
Moligand™, ≥99% |
|
|
阿拉丁 | P420608-1ml | 1ml | 现货 |
PF-04620110 PF-04620110 |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ008UJ2-10mg | 10mg | 期货,请咨询 |
PF-04620110; 反式-4-[4-(4-氨基-7... PF-04620110 |
99% |
|
|
凯为 | JZ008UJ2-25mg | 25mg | 期货,请咨询 |
PF-04620110; 反式-4-[4-(4-氨基-7... PF-04620110 |
99% |
|
|
凯为 | JZ008UJ2-50mg | 50mg | 期货,请咨询 |
PF-04620110; 反式-4-[4-(4-氨基-7... PF-04620110 |
99% |
|
|
凯为 | JZ008UJ2-100mg | 100mg | 期货,请咨询 |
PF-04620110; 反式-4-[4-(4-氨基-7... PF-04620110 |
99% |
|
|
毕得 | BD245855-10mg | 10mg | 现货 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-50mg | 50mg | 现货 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-100mg | 100mg | 现货 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
毕得 | BD245855-25mg | 25mg | 现货 |
2-(反式-4-(4-(4-氨基-5-氧代-7,8-二氢... 2-(trans-4-(4-(4-Amino-5-oxo... |
99% |
|
|
Matrix | MA100452-250mg | 250mg | 3-4周 |
2-(trans-4-(4-(4-Amino-5-oxo... 2-(trans-4-(4-(4-Amino-5-oxo... |
95+% | 咨询 | 请联系客服购买! |
Matrix | MA100452-1g | 1g | 3-4周 |
2-(trans-4-(4-(4-Amino-5-oxo... 2-(trans-4-(4-(4-Amino-5-oxo... |
95+% | 咨询 | 请联系客服购买! |
Sigma | PZ0207-5MG | 5mg | 请咨询 |
PF-04620110 PF-04620110 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
Sigma | PZ0207-25MG | 25mg | 请咨询 |
PF-04620110 PF-04620110 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
源叶 | S81211-5mg | 5mg | 期货,请咨询 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-10mg | 10mg | 期货,请咨询 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-50mg | 50mg | 期货,请咨询 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-25mg | 25mg | 期货,请咨询 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S81211-100mg | 100mg | 期货,请咨询 |
PF-04620110,DGAT-1抑制剂 PF-04620110 |
≥99% |
|
|
源叶 | S56489-1ml | 1ml | 期货,请咨询 |
PF-04620110 PF-04620110 |
10mM in DMSO |
|
|
Target Mol | T6937-2mg | 2mg | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Target Mol | T6937-5mg | 5mg | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Target Mol | T6937-10mg | 10mg | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Target Mol | T6937-50mg | 50mg | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Target Mol | T6937-1mL | 1mL | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Target Mol | T6937-25mg | 25mg | 现货 |
化合物 PF-04620110 PF-04620110 |
99.82% |
|
|
Am | A853379-5mg | 5mg | 期货,请咨询 |
PF-04620110 PF-04620110 |
98% |
|
|
Am | A853379-100mg | 100mg | 期货,请咨询 |
PF-04620110 PF-04620110 |
98% |
|
|
Am | A853379-1mg | 1mg | 期货,请咨询 |
PF-04620110 PF-04620110 |
98% |
|
|
Am | A853379-50mg | 50mg | 期货,请咨询 |
PF-04620110 PF-04620110 |
98% |
|
|
Am | A853379-10mg | 10mg | 期货,请咨询 |
PF-04620110 PF-04620110 |
98% |
|
|
MCE | HY-13009-100mg | 100mg | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|
MCE | HY-13009-50mg | 50mg | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|
MCE | HY-13009-10mg | 10mg | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|
MCE | HY-13009-10mM*1mL | 10mM*1mL | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|
MCE | HY-13009-5mg | 5mg | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|
MCE | HY-13009-1mg | 1mg | 现货 |
PF-04620110 PF-04620110 |
98.86% |
|
|